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Abstract
Background: Medicines are a main therapeutic intervention provided within hospitals and their proper use in the
outpatient setting is important for patients and the community. The objective of this study was to evaluate
drug use patterns in the outpatient departments (OPDs) of two tertiary care hospitals (Bahawal Victoria Hospital and
Civil Hospital) in the Bahawalpur district of the Punjab province of Pakistan by employing the standard World
Health Organization/International Network of Rational Use of Drugs (WHO/INRUD) drug use indicators.
Methods: A descriptive, cross-sectional study design was employed. For assessing the prescribing indicators a
sample of 2400 prescriptions were systematically reviewed out of a total of 1,560,000 prescriptions written from
1st April 2014 to 31st March 2015. A total of 600 randomly selected patients and all pharmacy personnel were
observed and interviewed to investigate the patient-care and facility-specific indicators. We used the published
ideal standards for each of the WHO/INRUD indicators for comparison purposes.
Results: Among the prescribing indicators, the average number of drugs per prescription was 2.8 (SD = 1.3), the
drugs prescribed by generic name were 56.6 %, the encounters with an antibiotic prescribed were 51.5 %, no
injections were prescribed and 98.8 % of the drugs prescribed were from the Essential Drugs List (EDL). Among
the patient-care indicators, the average consultation time was 1.2 min (SD = 0.8), the average dispensing time
was 8.7 s (SD = 4.9), the percentage of drugs actually dispensed was 97.3 %, the percentage of drugs adequately
labeled was 100 % and the patients’ knowledge of correct dosage schedule was 61.6 %. Among the facility-specific
indicators, all OPDs had a copy of the EDL and 72.4 % of the key drugs were available in stock.
Conclusion: Irrational use of drugs was observed in both OPDs. Polypharmacy, brand prescribing, over-prescribing of
antibiotics, short consultation and dispensing times, lack of patients’ knowledge about prescribed medicines and
unavailability of all key drugs in stock were the major issues that need attention of the healthcare authorities. This study
necessitates the requirement to implement the relevant WHO recommended core interventions to promote rational
use of medicines in these hospital-based OPDs.
Keywords: Rational, Use of drugs, Prescribing pattern, Patient-care, Facility-specific
* Correspondence: pharmacist_atif@yahoo.com; azeem634@hotmail.com
1Department of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur,
Pakistan
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Atif et al. Journal of Pharmaceutical Policy and Practice  (2016) 9:27 
DOI 10.1186/s40545-016-0076-4
Background
The World Health Organization (WHO) defines rational
use of medicines as “patients receive medications ap-
propriate to their clinical needs, in doses that meet
their own individual requirements, for an adequate
period of time, and at the lowest cost to them and
their community” [1]. According to the WHO, more
than 50 % of all medicines are prescribed, dispensed
or sold inappropriately [2]. As a result, patients are
unable to follow their treatment plan correctly. One of
the consequences of irrational use of medicines is lack
of patients’ confidence in the healthcare system. In the
developing countries, for example Pakistan, the problem is
exacerbated by limited resources and inadequate drug
policy [3].
The most common causes of inappropriate use of
medicines are; self-medication, polypharmacy, inappro-
priate use of antibiotics, overuse of injectable medicines
and prescribing of medicines outside of usual clinical
practice guidelines [2]. Some other causes of irrational
use of medicines include knowledge, attitudes and
practices of patients and practitioners, the working en-
vironment, the drug supply system, legal regulations,
information and misinformation about the medicines
and profit intentions of the pharmaceutical companies
[4–8]. Unsafe and ineffective treatment, prolongation
of disease state, harm and distress to the patients, in-
creased cost of treatment, aggravation of chronic con-
ditions for example diabetes, hypertension, epilepsy
and neurological disorders, and antibiotic resistance
are some of the consequences of the irrational use of
medicines [9].
The fundamental steps to limit the irrational use of
medicines is to identify the types, extent and reasons of
their irrational use [2]. In the 1990′s, WHO in collab-
oration with the International Network of Rational Use
of Drugs (INRUD) developed standard indicators to
evaluate drug use practices at healthcare centers [10].
Though originally developed to assess drug use pat-
terns in primary healthcare centers, these indicators
have been used at tertiary healthcare facilities for similar
purposes [11–13]. The indicators called “core drug use in-
dicators” are classified into prescribing, patient-care and
facility-specific indicators (Table 1).
The purpose of this study was to investigate the drug
use patterns at ten outpatient departments (OPDs) in
each of the two tertiary care hospitals in the Bahawal-
pur district of Southern Punjab, Pakistan. The findings
are able to be used as a benchmark for the healthcare
facilities and as a basis for further follow-up of quality
of drug use. In the context of Pakistan, the findings
of this study will further help policymakers to take




The study was conducted in the Bahawal Victoria Hos-
pital (BVH) and the Civil Hospital of Bahawalpur district
of the Punjab province of Pakistan. Ten OPDs from each
of the two hospitals were included. The BVH, located in
the central part of the city, is a 1600-bed tertiary care
hospital with all standard medical and surgical facilities.
The Civil Hospital is newly established 400-bed tertiary
care hospital.
Study design and outcome measures
This descriptive, cross-sectional study was conducted to
evaluate the performance of the selected OPDs in three
general areas related to rational drug use; prescribing,
patient-care and facility. The optimal values for the
prescribing [11], patient-care and facility-specific indi-
cators [9, 14] were adopted from previous studies. For
this study, the optimal values for the consultation and
dispensing times were set as ≥10 min and ≥90 s, re-
spectively (Table 1).
Zhang and Zhi developed an index system to gauge
the performance of a healthcare system in terms of
drug utilization [14, 15]. For the calculation of non-
polypharmacy, rational antibiotic and injection safety
indices, the following formula was used;
Index ¼ Optimal value
Observed value
Table 1 Core drug use indicators and their optimal values
Core drug use indicators Optimal values
Prescribing Indicators
Average number of drugs prescribed per patient
encounter
1.6–1.8
Percent medicines prescribed by generic name 100
Percent encounters with an antibiotic prescribed 20.0–26.8
Percent encounters with an injection prescribed 13.4–24.1
Percent medicines prescribed from essential
medicines list or formulary
100
Patient-Care Indicators
Average consultation time (minutes) ≥10
Average dispensing time (seconds) ≥90
Percent medicines actually dispensed 100
Percent medicines adequately labeled 100
Percent patients with knowledge of correct doses 100
Facility-Specific Indicators
Availability of essential medicines list or formulary
to practitioners
100
Percent key medicines available 100
Note: Core drug use indicators are obtained from World Health Organization
source [2, 10]
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All other indices (index of generic name, index of Essen-
tial Drugs List (EDL), consultation time index, dispensing
time index, index of drugs actually dispensed, index of la-
belling of drugs, index of patients’ knowledge, index of
EDL availability and index of key drugs availability in
stock) were calculated by the following formula;
Index ¼ Observed value
Optimal value
The optimal index for all indicators was set as 1. The
values closer to 1 indicated rational drug use and vice
versa. The Index of Rational Drug Prescribing (IRDP)
was calculated for all OPDs by adding the index values
of all prescribing indicators. Based on the IRDP values,
the OPDs were ranked from 1 to 10 (rank 1 for the
higher IRDP value and rank 10 for the lower IRDP). In a
similar fashion, the Index of Rational Patient-Care Drug
Use (IRPCDU) and the Index of Rational Facility-
Specific Drug Use (IRFSDU) were calculated. Finally, the
Index of Rational Drug Use (IRDU) was calculated for
all OPDs by adding up the total of IRDP, IRPCDU and
IRFSDU. Subsequently, OPDs were ranked based on the
IRDU indices. The OPD with higher IRDU value was
considered the best performing OPD in terms of rational
drug use, and was given the first rank.
Data collection
The standard core drug use indicator forms were used
to collect the data [10]. The WHO guidelines and methods
were observed to ensure data reliability [10]. The data
was collected during the period 1st December 2014 to
31st March 2015.
Prescribing indicators
Trained data collectors retrospectively selected 2,400
prescriptions (120 prescriptions per OPD) out of the
total 1,560,000 prescriptions written during the 1 year
period (i.e., 1st April 2014 to 31st March 2015). A system-
atic random sampling technique was used to collect the
data and the sampling unit was the patient encounters at
each of the OPDs [11]. To minimize the sampling bias
(seasonal alterations or supply cycle of medicines), the
encounters per year were uniformly divided into four
quarters and 30 prescriptions were randomly selected
from each quarter, irrespective of acute or chronic ill-
nesses, including a mixture of health conditions and a
range of patient ages.
Patient-care indicators
Patients visiting the OPDs, between 1st December 2014
and 31st March 2015 for diagnosis and treatment of
health problems were invited to participate in the study. A
total of 600 patients (30 patients per OPD) were randomly
selected during the OPD hours. Trained data collectors
explained the purpose of the study to the respondents and
obtained their consent before data collection began. The
consented patients were observed and interviewed to ob-
tain the required information [10].
Facility-specific indicators
For the facility-specific indicators, all available pharmacy
personnel were invited to participate in the study and
the consented participants were interviewed to obtain
the required information [10].
Data analysis
Statistical Package for Social Sciences (IBM, SPSS Statis-
tics for Windows, version 21.0. Armonk, NY: IBM Corp.)
was used for data analysis. Descriptive statistics such as
frequencies, percentages, average/mean, and standard de-
viation were used to present the data.
Results
Prescribing indicators
The average number of drugs per encounter was 2.82
(SD = 1.3) and percentage of drugs prescribed by the
generic name was 56.6 % (SD = 1.2). Over half (51.5 %,
SD = 0.5) of the prescriptions had an antibiotic pre-
scribed. There was no injection encounter recorded. The
percentage of drugs prescribed from the EDL was 98.8 %
(SD = 1.3) (Table 2).
Patient-care and facility-specific indicators
The average consultation time was 1.2 (SD = 0.8) minutes
and the average dispensing time was 8.7 (SD = 4.9)
seconds. 97.3 % (SD = 1.3) of drugs on the prescriptions
were actually dispensed. All dispensed drugs were ad-
equately labelled. Over two-thirds (61.6 %, SD = 0.6) of pa-
tients had the correct knowledge about the dosage of the
medications they had been prescribed (knowledge about
when and in what quantity the medicine should be taken).
A copy of the EDL was available 100 % (SD = 0.0) of the
time. Nearly three-quarters (72.4 %, SD = 0.4) of key drugs
were available in stock (Table 3).
The IRDP values show that the gynecology OPD was
performing well in the BVH and the pulmonology OPD
was the leading department in the Civil Hospital. Simi-
larly, the IRPCDU values indicated that the surgery OPDs
in both hospitals showed better results compared with
all other OPDs. The gynecology, ENT and pediatrics
OPDs in the BVH and the ophthalmology OPD in the
Civil Hospital showed relatively better results with re-
gard to facility-specific indicators. Overall, the IRDU
values showed that the gynecology OPD in the BVH
and the pulmonology OPD in the Civil Hospital were
the best performing OPDs (Table 4) in terms of core
drug indicators.
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Discussion
This study set out to assess drug use practices through
analysis of the core indicators of the WHO/INRUD
across a range of OPDs in two tertiary care hospitals in
Pakistan. Though irrational prescribing practices exist all
over the world [9], the gravity of the problem is high in
low and middle income countries and so Pakistan makes
for a sensible context in which to explore this issue. Our
study reports: a higher number of drugs prescribed per
prescription, over-use of antibiotics, low rate of prescrib-
ing by generic name and short dispensing and consulting
times. Key drugs were available less than three-quarters
(72.4 %) of the time. Patient knowledge of correct doses
was found to be lower than like studies in other develop-
ing countries. On the positive side, the EDL was always
available in these OPDs and 98.8 % of drugs prescribed
were from the list. The implications of these findings are
discussed in terms of previous studies and future policy,
practice and research.
Prescribing indicators
Our findings suggest the average number of drugs per
prescription was higher than the admissible range and
there was considerable over-prescribing of antibiotics.
Table 3 WHO/INRUD patient-care and facility-specific indicators in two tertiary care hospitals of Bahawalpur (N = 600)













% key drugs in
the stock
BVH Civil BVH Civil BVH Civil BVH Civil BVH Civil BVH Civil BVH Civil
Gynecology 2.2 0.9 7.8 6.7 100 100 100 100 47.0 73.0 100 100 100 80
Ophthalmology 0.7 0.6 4.8 5.9 100 100 100 100 87.0 67.0 100 100 43.0 86
Dermatology 1.1 0.7 9.0 5.1 67.6 100 100 100 73.0 70.0 100 100 50.0 75
ENT 0.9 0.7 7.5 6.3 94.9 100 100 100 27.0 50.0 100 100 100 71
Surgery 1.1 2.1 17.2 6.8 100 100 100 100 100 67.0 100 100 50.0 75
Pulmonology 1.3 2.1 7.6 8.0 96.7 100 100 100 70.0 47.0 100 100 71.0 71
Dental 1.7 0.7 8.0 6.2 100 100 100 100 40.0 60.0 100 100 75.0 50
Cardiology 1.6 2.4 18.6 8.6 100 100 100 100 67.0 50.0 100 100 75.0 75
Pediatrics 1.4 0.7 6.1 7.4 86.0 100 100 100 47.0 60.0 100 100 100 67
Medical 1.1 0.7 18 7.4 100 100 100 100 67.0 63.0 100 100 75.0 58
Mean 1.3 1.1 10.5 6.8 94.5 100 100 100 62.5 60.7 100 100 73.9 70.8
MEAN (SD)a 1.2 (0.8) 8.7 (4.9) 97.3 (1.3) 100 (0.0) 61.6 (0.6) 100 (0.0) 72.4 (0.4)
aCalculated based on the total sample size, OPD outpatient department, EDL essential drugs list, BVH Bahawal Victoria Hospital, ENT ear, nose & throat
Table 2 WHO/INRUD prescribing indicators in two tertiary care hospitals of Bahawalpur (N = 2400)
OPD wards Prescribing indicators
Average drugs/
encounter
% drugs prescribed by
generic name
% encounters with an
antibiotic prescribed
% encounters with an
injection prescribed
% drugs prescribed from
EDL/formulary
BVH Civil BVH Civil BVH Civil BVH Civil BVH Civil
Gynecology 3.1 2.8 66.0 51.3 38.0 43.3 0.0 0.0 100 87.1
Ophthalmology 1.2 1.6 28.2 84.1 48.0 71.6 0.0 0.0 100 99.4
Dermatology 2.2 2.8 44.2 54.4 48.0 35.0 0.0 0.0 100 98.8
ENT 3.2 2.8 72.5 62.2 80.0 55.8 0.0 0.0 100 100
Surgery 3.2 2.7 62.5 55.7 86.0 28.3 0.0 0.0 100 99.3
Pulmonology 3.7 2.0 55.6 56.0 54.1 6.6 0.0 0.0 100 98.3
Dental 2.8 2.5 45.1 39.3 95.0 95.0 0.0 0.0 100 99.7
Cardiology 4.6 4.1 52.8 67.0 0.0 10.0 0.0 0.0 100 95.5
Pediatrics 2.5 3.0 57.4 53.5 65.0 84.1 0.0 0.0 100 98.9
Medical 3.2 2.5 65.1 58.6 39.0 47.5 0.0 0.0 100 100
Mean 3.0 2.7 54.9 58.2 55.3 47.7 0.0 0.0 100 97.7
MEAN (SD)a 2.8 (1.3) 56.6 (1.2) 51.5 (0.5) 0.0 (0.0) 98.8 (1.3)
aCalculated based on the total sample size, OPD outpatient department, EDL essential drugs list, BVH Bahawal Victoria Hospital, ENT, ear, nose & throat
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Table 4 Index of rational drug use in two tertiary care hospitals of Bahawalpur
IRDU OPDs




BVH 0.58 1.00 0.82 0.56 0.56 0.49 0.64 0.40 0.72 0.56
Civil 0.64 1.00 0.64 0.64 0.67 0.90 0.72 0.44 0.60 0.72
Generic name index BVH 0.66 0.28 0.44 0.72 0.62 0.56 0.45 0.53 0.57 0.65
Civil 0.51 0.84 0.54 0.62 0.56 0.56 0.39 0.67 0.53 0.59
Rational antibiotic
index
BVH 0.71 0.56 0.56 0.34 0.31 0.49 0.28 1.00 0.41 0.69
Civil 0.62 0.37 0.76 0.48 0.95 1.00 0.28 1.00 0.32 0.56
Injection safety index BVH 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Civil 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Essential drugs list
index
BVH 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Civil 0.87 0.99 0.99 1.00 0.99 0.98 0.99 0.95 0.99 1.00
IRDP BVH 3.95 3.84 3.82 3.62 3.49 3.54 3.37 3.93 3.70 3.90
Civil 3.64 4.20 3.93 3.74 4.17 4.44 3.38 4.06 3.44 3.87
Rank BVH 1 4 5 7 9 8 10 2 6 3




BVH 0.22 0.07 0.11 0.09 0.11 0.13 0.17 0.16 0.14 0.11
Civil 0.09 0.06 0.07 0.07 0.21 0.21 0.07 0.24 0.07 0.07
Dispensing time index BVH 0.09 0.05 0.10 0.08 0.19 0.08 0.09 0.21 0.07 0.20
Civil 0.07 0.06 0.06 0.07 0.08 0.09 0.07 0.10 0.08 0.08
Dispensed drugs index BVH 1.00 1.00 0.67 0.94 1.00 0.97 1.00 1.00 0.86 1.00
Civil 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Labeled drugs index BVH 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Civil 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Patients’ knowledge
index
BVH 0.47 0.87 0.73 0.27 1.00 0.70 0.40 0.67 0.47 0.67
Civil 0.73 0.67 0.70 0.50 0.67 0.47 0.60 0.50 0.60 0.63
IRPCDU BVH 2.78 2.99 2.61 2.38 3.30 2.88 2.66 3.04 2.54 2.98
Civil 2.89 2.79 2.83 2.64 2.96 2.77 2.74 2.84 2.75 2.78
Rank BVH 6 3 8 10 1 5 7 2 9 4
Civil 2 5 4 10 1 7 9 3 8 6
Facility-Specific Indicators
Index of EDL BVH 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Civil 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Index of key drugs in
stock
BVH 1.00 0.43 0.50 1.00 0.50 0.71 0.75 0.75 1.00 0.75
Civil 0.80 0.86 0.75 0.71 0.75 0.71 0.50 0.75 0.67 0.58
IRFSDU BVH 2.00 1.43 1.50 2.00 1.5 1.71 1.75 1.75 2.00 1.75
Civil 1.80 1.86 1.75 1.71 1.75 1.71 1.50 1.75 1.67 1.58
Rank BVH 1 5 4 1 4 3 2 2 1 2
Civil 2 1 3 4 3 4 7 3 5 6
Grand Total
IRDU BVH 8.73 8.26 7.93 8.00 8.29 8.13 7.78 8.72 8.24 8.63
Civil 8.33 8.85 8.51 8.09 8.88 8.92 7.62 8.65 7.86 8.23
Atif et al. Journal of Pharmaceutical Policy and Practice  (2016) 9:27 Page 5 of 8
We also found that just over half (56.6 %) of drugs were
prescribed by the generic name whilst the aim is for 100 %
prescribing by generic. These findings are alarming for a
number of reasons. Polypharmacy can adversely influence
treatment outcomes in a way that patients are at a higher
risk of adverse events [16]. Similarly, unnecessarily pre-
scribed medicines and those prescribed by brand names
can put extra financial pressure on patients as well as
healthcare budgets [2]. According to the WHO, it is the
aim that generic prescribing takes precedent over origin-
ator brand prescribing because it helps with improved
communication and clarity amongst healthcare providers.
Moreover, generic medicines are less expensive than ori-
ginator branded medicines [17]. The over-use of antibi-
otics is occurring internationally and leads to increase in
adverse drug reactions and hospitalization, but also con-
tributes significantly to an increase in antibiotic resistance
and Pakistan appears no different [18].
In our study, we found that injectable medicines were
not prescribed and the EDL was followed in 98.8 % of
the prescriptions. It is likely that injectable medicines
were not prescribed because in Pakistan they are more
commonly reserved for emergency cases, and in the con-
text of this study, such patients would be managed in
Accident and Emergency (A&E) departments, and A&E
departments were not included in our study.
We have summarized the findings of closely related
studies, irrespective of country of origin, to facilitate
comparisons (Table 5). With regard to prescribing indi-
cators, our findings are closely related to earlier studies
in this field. For example, studies from Afghanistan (3.9)
[19], India (5.6) [20], Ghana (4.8) [21] and Nigeria (5.2)
[22] showed higher numbers of drugs per prescription.
Similarly, in studies from Andorra (6 %) [23], Palestine
(5.5 %) [24], Lebanon (2.9 %) [25] and India (11.5 %) [3],
generics were less commonly prescribed than was seen
in this study. In contrast to this, studies from Cambodia
(99.8 %) [26], Timor-Leste (92 %) [27] and Ethiopia (98.7 %)
[11] showed higher levels of generic prescribing, which
might be the consequence of more effective and better
enforced drug policies in these countries; or simply a lack
of very expensive originator branded drugs.
Patient-care indicators
The results of the current study demonstrate that the
average consultation and dispensing times were 1.2 min
and 8.7 s, respectively (dispensing time = time when a pa-
tient reaches and leaves the pharmacy counter. Waiting
time not included). This is much less than the proposed
optimal norms. The shorter consultation and dispensing
times reported in our study could be a result of the large
number of patients attending the OPDs in these two ter-
tiary care hospitals. Insufficient consultation time leads to
inappropriate patient examination and history taking and
poor physician–patient interactions [9]. On the other hand,
shorter dispensing time is insufficient to provide complete
Table 4 Index of rational drug use in two tertiary care hospitals of Bahawalpur (Continued)
Rank BVH 1 5 9 8 4 6 10 2 7 3
Civil 6 3 5 8 2 1 10 4 9 7
OPD outpatient department, EDL essential drugs list, BVH Bahawal Victoria Hospital, ENT, ear, nose & throat, IRDP index of rational drug prescribing, IRPCDU, index
of rational patient-care drug use, IRFSDU index of rational facility-specific drug use, IRDU index of rational drug use
Table 5 Summary of core drug use indicator studies from developed and developing countries
Indicators Study reference
Developed countries Developing countries
[14, 35] [38] [39] [40] [41] [9] [42] [26] [22] [43]
Average no. of drugs per encounter 2.4 0.7 2.9 2.6 2.2 2.5 2.2 2.4 3.0 2.2
% Generic 61.2 —— 17.7 14.3 4.4 95.4 74 99.8 63.1 99
% Antibiotic 32.2 10.4 39.1 26.2 13.5 39.2 37 66 54.2 43
% Injection 2 0.0 9.1 8.3 1.6 9.9 11 2.4 38.0 18
% drugs EDL 99.2 —— —— 19.8 —— 95.4 78 99.7 75.6 98.8
Average consultation time (minutes) 7.3 22.5 2.8 —— —— 7.1 5.8 4.4 6.1 3.7
Average dispensing time (seconds) 100 —— 54.6 —— —— 47.4 17 234 18.1 37
% Drugs dispensed 99.6 —— 97.9 —— —— 95.9 66 100 99.1 84.5
% Drugs labeled 10 —— 66.9 —— —— 0.0 63 0.0 55.9 86.2
% Patient knowledge 79.3 70 26.9 —— —— 94 54 55 86.5 81.7
% EDL availability 90 —— ——— —— —— 80 50 100 100 100
% Drugs in stock 59.2 ——— ———— —— —— 78.3 55 86.6 91.7 86.5
Saudi Arabia [14, 35]; Sweden [38]; Kuwait [39]; Bahrain [40]; United Arab Emirates [41]; Egypt [9]; Brazil [42]; Cambodia [26]; Swaziland [22]; Mozambique [43]
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drug related information to the patients. Several studies
from various under-developed countries reported almost
similar findings [22, 28, 29]. However, studies from Nigeria
[30], Nepal [31] and Ethiopia [32] showed better results
probably because of adequate patient-to-healthcare worker
ratio. According to our findings, 61.6 % of the patients had
knowledge of correct dosage schedule for all prescribed
drugs. This is much lesser than the optimal value of 100 %.
It was higher than that reported in Tanzania (37.9 %) [33]
and Malawi (27 %) [34] but much lower than high achiev-
ing nations such as Nigeria (93 %) [30] and Egypt (94 %)
[9]. Patient’s knowledge about correct dosage is highly sig-
nificant to avoid over use and abuse of drugs, and could
prevent adverse events that ultimately affect patients’ health
and quality of life.
In contrast to dispensing time, consultation time, and
patients’ knowledge of correct dosage, the percentage of
drugs actually dispensed and the drug labelling practices
were close to the optimal values. This may be due to the
fact that the medical professionals were aware of the
drugs available in the hospital and followed appropriate
guidelines with regards EDL use.
Facility-specific indicators
The study revealed that all OPDs had a copy of the EDL
which is in line with the proposed norm. However, only
72.4 % of key drugs were available in on hand in these
OPDs. Shortage of any essential drugs in the hospital is
disadvantageous for patients in that doctors may not be
able to prescribe the correct drugs or they are limited to
prescribing out-of-stock medicines which may pose extra
fiscal burden on the patients’ through “out of pocket”
expense. Similar to our findings, studies from Saudi Arabia
(59.2 %) [35], Nigeria (62 %) [36], Malawi (67 %) [34] and
Ethiopia (65 %) [32] showed lower values for availability of
key drugs in the stock. In contrast, Tanzania (100 %) [37],
Swaziland (91.7 %) [22], Nigeria (90.9 %) [22] and Nepal
(90 %) [31] appear to report better results.
Implications
In addition to the implications for literature (outlined
previously) there are also considerations for policy, prac-
tice and future research. Our findings will benefit policy
makers who have an interest in process improvement
and service delivery performance. The finding that only
72.4 % of key drugs were available throughout the study
warrants consideration by policy-makers, who may need
to put incentives or legislation in place to ensure better
access to these essential drugs. There are also areas of
practice which could be improved on particularly around
the potential over-use of antibiotics and the prescribing of
drugs by generic name. The two hospitals would benefit
from having guidelines in place for the optimal and re-
sponsible use of antibiotics which could be monitored and
feedback provided on a regular basis to prescribers. An
awareness campaign and incentives could also be put in
place to increase the prescribing of drugs by generic name.
This intervention could be set up as a program evaluation
and add to the current research agenda in this area. One
approach could be to implement and evaluate WHO rec-
ommended core interventions on a pilot scale to devise
policies to achieve improved performance and the long-
term benefits associated with this.
Conclusion
Polypharmacy, brand prescribing, over-prescribing of
antibiotics, short consultation and dispensing times, lack
of patients’ knowledge about prescribed medicines and
unavailability of all key drugs in stock were the major
issues that need attention of the healthcare authorities.
WHO recommended core interventions could be im-
plemented on pilot scale to devise policies to achieve
long-term benefits.
Limitations
As with any study there are limitations which need to be
considered.. First, our findings could not be generalized
for the whole of Pakistan and should not be extrapolated to
the international environment. The findings do however
add to a growing literature, particularly around medicines
use and pharmaceutical health systems in developing
countries. It is also important to consider that a uniform
healthcare policy is implemented throughout Pakistan and
medical graduates from various institutions are working in
the Bahawalpur district. It is expected that the practices
would be similar to other tertiary care hospitals in
Pakistan. Second, different OPDs in each of the tertiary
care hospitals demonstrate varying degrees of optimal
drug use and systems to support these. To address this
bias, the mean values were calculated for each of the
OPD, separately. Third, very limited data on core drug
use indicators is available in tertiary care settings and
we compare our findings with international data based
on primary healthcare settings.
Abbreviations
EDL, essential drugs list; INRUD, International Network for the Rational Use of
Drugs; IRDP, index of rational drug prescribing; IRDU, index of rational drug
use; IRFSDU, index of rational facility-specific drug use; IRPCDU, index of
rational patient-care drug use; SPSS, statistical package for social sciences;
WHO, World Health Organization
Acknowledgements
The authors would like to thank the record officers at the BVH and Civil for
their help in data retrieving. No funding was involved in the preparation of
this article or in the decision to submit it for publication.
Authors’ contributions
MAT conceptualized and designed the study. SS also participated in design
of the study. MRS, MAZ, DU, AR, ARS and MA collected, analyzed and
interpreted the data. MRS, MAZ and MAT drafted the manuscript. SS and
Atif et al. Journal of Pharmaceutical Policy and Practice  (2016) 9:27 Page 7 of 8
MAT critically revised the manuscript. All authors read and approved final
version of the manuscript.
Competing interests
The authors declare that they have no competing interests.
Ethics approval and consent to participate
The study was based on the Code of Ethics of the Declaration of Helsinki.
The ethical approval was granted by the Pharmacy Research Ethics Committee
(PREC) at the Islamia University Bahawalpur (Reference: 54-2014/PREC, dated
November 16, 2014).
Author details
1Department of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur,
Pakistan. 2School of Management, Massey University, Auckland, New Zealand.
Received: 26 November 2015 Accepted: 12 July 2016
References
1. World Health Organization. The Rational use of drugs: report of the
conference of experts, Nairobi, 25–29 November 1985. 1987. http://apps.
who.int/medicinedocs/en/d/Js17054e/. Accessed October 18 2015
2. World Health Organization. Promoting rational use of medicines: core
components - WHO policy perspectives on medicines. 2002. http://apps.
who.int/medicinedocs/en/d/Jh3011e/. Accessed October 18 2015
3. Kshirsagar M, Langade D, Patil S, Patki P. Prescribing patterns among medical
practitioners in Pune, India. Bull World Health Organ. 1998;76(3):271–5.
4. World Health Organization. The use of essential drugs: sixth report of the
WHO Expert Committee. 1995. http://apps.who.int/iris/handle/10665/37340.
Accessed October 18 2015
5. Geest S, Hardon A, Whyte S. Planning for essential drugs: are we missing
the cultural dimension. Health Policy Plan. 1991;5(2):182–5.
6. Hogerzeil HV. Promoting rational prescribing: an international perspective.
Br J Clin Pharmacol. 1995;39(1):1–6.
7. Sachs L, Tomson G. Medicines and culture–a double perspective on drug
utilization in a developing country. Soc Sci Med. 1992;34(3):307–15.
8. Abdo-Rabbo A, Haaijer-Ruskamp F, Basharahil K. Baseline prescribing and
health facility indicators in Yemen. J Fac Med Baghdad. 2000;42(4):824–9.
9. Akl OA, El Mahalli AA, Elkahky AA, Salem AM. WHO/INRUD drug use
indicators at primary healthcare centers in Alexandria, Egypt. J Taibah
Univers Med Sci. 2014;9(1):54–64.
10. World Health Organization. How to investigate drug use in health facilities:
selected drug use indicators. 1993. http://apps.who.int/medicinedocs/en/d/
Js2289e/. Accessed October 18 2015
11. Desalegn AA. Assessment of drug use pattern using WHO prescribing
indicators at Hawassa University teaching and referral hospital, south
Ethiopia: a cross-sectional study. BMC Health Serv Res. 2013;13:170.
12. Malangu N. Indicators in a Zaire hospital. INRUD News. 1992;3(1):2.
13. Isah A, Ohaju‐Obodo J, Isah E, Ozemoya O. Drug use profile in a Nigerian
city hospital. Pharmacoepidemiol Drug Saf. 1997;6(5):319–24.
14. El Mahalli A. WHO/INRUD drug prescribing indicators at primary health
care centres in Eastern province, Saudi Arabia. East Mediterr Health J.
2012;18(11):1091–6.
15. Zhang Y, Zhi M. Index system, appraising method for comprehensive
appraisal. J North Jiaotong Univer. 1995;19:393–400.
16. Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug-
related events, and potential adverse drug interactions in elderly patients
presenting to an emergency department. Ann Emerg Med. 2001;38(6):666–71.
doi:10.1067/mem.2001.119456.
17. Atif M, Azeem M, Sarwar MR. Potential problems and recommendations
regarding substitution of generic antiepileptic drugs: a systematic review of
literature. SpringerPlus. 2016;5:182.
18. World Health Organization. Antimicorbial resistance. 2015. http://www.who.
int/mediacentre/factsheets/fs194/en/. Accessed June 19 2016
19. Ahmad F, Danish AS, Rahmani MR. Prescribing practice at private clinics in
jalalabad, Afghanistan. INRUD News. 1995;5(2):21
20. Akhtar M, Vohora D, Pillai K, Dubey K, Roy M, Najmi A, et al. Drug
prescribing practices in paediatric department of a north indian university
teaching hospital. Asian J Pharm Clin Res. 2012;5(1):146–9.
21. Bosu W, Ofori-Adjei D. An audit of prescribing practices in health care facilities
of the Wassa West district of Ghana. West Afr J Med. 1999;19(4):298–303.
22. S.O.N. Uzoma AL, Eva Ombaka. Drug Use studies in Church Facilities in
Africa. INRUD News. 1995;5(1):20.
23. Vallano A, Montane E, Arnau JM, Vidal X, Pallares C, Coll M, et al. Medical
speciality and pattern of medicines prescription. Eur J Clin Pharmacol. 2004;
60(10):725–30. doi:10.1007/s00228-004-0802-8.
24. Fattouh R, Abu HB. Impact of using essential drug list: analysis of drug use
indicators in Gaza Strip. East Mediterr Health J. 2010;16(08):886–92.
25. Hamadeh GN, Dickerson LM, Saab BR, Major SC. Common prescriptions in
ambulatory care in Lebanon. Ann Pharmacother. 2001;35(5):636–40.
26. Chareonkul C, Khun VL, Boonshuyar C. Rational drug use in Cambodia:
study of three pilot health centers in Kampong Thom Province. Southeast
Asian J Trop Med Public Health. 2002;33(2):418–24.
27. Stanley Chindove AX. Nelson Martins. Medicines prescribing patterns for the
treatment of common diseases at community health centres in 3 districts of
Timor-leste. Int J Pharm. 2012;2(3):439–44.
28. Chattopadhyay A, Mondal T, Saha TK, Dey I, Sahu BK, Bhattacharya J. An
audit of prescribing practices in CGHS dispensaries of Kolkata, India. IOSR J
Dent Med Sci. 2013;8(01):32–7.
29. Hogerzeil H, Ross-Degnan D, Laing R, Ofori-Adjei D, Santoso B, Chowdhury
AA, et al. Field tests for rational drug use in twelve developing countries.
Lancet. 1993;342(8884):1408–10.
30. Henry CN, Ogaji IJ, Sariem CN. Drug use pattern with standard indicators in
Jos University Teaching Hospital Nigeria. West Afr J Pharm. 2013;24(1):88–93.
31. Kafle K. INRUD drug use indicators in Nepal: Practice patterns in health
posts in four districts. INRUD News. 1992;3(1):15.
32. Angamo MT, Wabe NT, Raju N. Assessment of patterns of drug use by using
World Health Organization’s prescribing, patient care and health facility
indicators in selected health facilities in Southwest Ethiopia. J App Pharm
Sci. 2011;01(07):62–6.
33. Nsimba SED. Assessing prescribing and patient care indicator for children
under five years old with malaria and other disease conditions in public
primary health care facilities. Southeast Asian J Trop Med Public Health.
2006;37(1):206–14.
34. Gelders S, World Health Organization. Drug use indicator survey, 1991-Malawi
Essential Drugs Programme.1992. http://apps.who.int/medicinedocs/en/d/
Js21679en/. Accessed October 18 2015
35. El Mahalli A, Akl O, Al-Dawood S, Al-Nehab A, Al-Kubaish H, Al-Saeed S,
et al. WHO/INRUD patient care and facility-specific drug use indicators at
primary health care centres in Eastern province, Saudi Arabia. East Mediterr
Health J. 2012;18(11):1086–90.
36. Bimo D. Report on Nigerian field test. INRUD news. 1992;3:9–10.
37. Massele AY, Nsimba SE, Rimoy G. Prescribing habits in church-owned
primary health care facilities in Dar Es Salaam and other Tanzanian coast
regions. East Afr Med J. 2001;78(10):510–4.
38. Tomson G. Pilot study of drug use indicators in Sweden. Inrud News. 1992;3(1):3.
39. Awad A, Al-Saffar N. Evaluation of drug use practices at primary healthcare
centers of Kuwait. Eur J Clin Pharmacol. 2010;66(12):1247–55.
40. Naseeb TA, Nasser MA. Drug prescribing indicators in primary health care
centers in Bahrain. Saudi Med J. 2005;26(9):1436–8.
41. Sharif S, Al-Shaqra M, Hajjar H, Shamout A, Wess L. Patterns of drug
prescribing in a hospital in dubai, United arab emirates. Libyan J Med. 2008;
3(1):10–2. doi:10.4176/070928.
42. Lopes A, Teixeira A, Gurgel M, Miranda M, Oliveira M, Oliveira M, et al. Drug
use of evaluation in health services in Fortaleza, Brasil. INRUD News. 1996;6:17.
43. Folkedal SF G, Banqueiro EG. Rational Drug Use Field Tests: Experience from
Mozambique. INRUD News. 1994;4(2):21.
Atif et al. Journal of Pharmaceutical Policy and Practice  (2016) 9:27 Page 8 of 8
